You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: May 13, 2024

Hengrui Pharma Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for HENGRUI PHARMA, and what generic and branded alternatives to HENGRUI PHARMA drugs are available?

HENGRUI PHARMA has seventeen approved drugs.

Summary for Hengrui Pharma

US Patents:	0
Tradenames:	15
Ingredients:	14
NDAs:	17

Drugs and US Patents for Hengrui Pharma

+ Get email alerts for changes to this table

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Hengrui Pharma	GADOBUTROL	gadobutrol	SOLUTION;INTRAVENOUS	215061-001	Nov 17, 2022	AP	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Hengrui Pharma	THIOTEPA	thiotepa	INJECTABLE;INJECTION	209150-001	May 4, 2018	AP	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Hengrui Pharma	FONDAPARINUX SODIUM	fondaparinux sodium	INJECTABLE;SUBCUTANEOUS	206812-004	May 15, 2018	AP	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Hengrui Pharma	CYCLOPHOSPHAMIDE	cyclophosphamide	INJECTABLE;INJECTION	204555-001	Oct 31, 2014	AP	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Hengrui Pharma	OXALIPLATIN	oxaliplatin	INJECTABLE;INTRAVENOUS	203869-002	Jun 18, 2014	AP	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Hengrui Pharma	DOCETAXEL	docetaxel	INJECTABLE;INJECTION	203170-001	Feb 15, 2017		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
Hengrui Pharma	DEXMEDETOMIDINE HYDROCHLORIDE	dexmedetomidine hydrochloride	INJECTABLE;INJECTION	209065-004	Jun 12, 2020	AP	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Hengrui Pharma

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.